DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report)'s stock had its "outperform" rating reaffirmed by Barrington Research in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $41.00 price target on the medical instruments supplier's stock. Barrington Research's price target would indicate a potential upside of 34.69% from the stock's current price.
A number of other research analysts also recently issued reports on XRAY. StockNews.com raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, January 19th. Piper Sandler lifted their price objective on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a "neutral" rating in a research report on Friday, January 12th. Needham & Company LLC reissued a "buy" rating and set a $42.00 target price on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Leerink Partnrs reissued an "outperform" rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Finally, SVB Leerink assumed coverage on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. They set an "outperform" rating and a $42.00 target price on the stock. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $39.50.
Read Our Latest Report on DENTSPLY SIRONA
DENTSPLY SIRONA Trading Up 0.3 %
Shares of DENTSPLY SIRONA stock traded up $0.08 during trading on Thursday, hitting $30.44. The stock had a trading volume of 1,350,342 shares, compared to its average volume of 3,417,594. The firm's fifty day simple moving average is $32.84 and its 200-day simple moving average is $32.87. The stock has a market cap of $6.31 billion, a PE ratio of -49.10, a PEG ratio of 1.25 and a beta of 0.98. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. DENTSPLY SIRONA has a 12 month low of $26.27 and a 12 month high of $43.24.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.01. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The business's revenue was up 3.0% on a year-over-year basis. During the same quarter last year, the business earned $0.46 EPS. As a group, sell-side analysts expect that DENTSPLY SIRONA will post 2.05 EPS for the current fiscal year.
Institutional Trading of DENTSPLY SIRONA
Several institutional investors and hedge funds have recently bought and sold shares of the business. Oak Thistle LLC acquired a new stake in DENTSPLY SIRONA during the 1st quarter valued at approximately $216,000. Cannon Global Investment Management LLC acquired a new stake in DENTSPLY SIRONA during the 1st quarter valued at approximately $461,000. Mather Group LLC. acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at $72,000. PNC Financial Services Group Inc. lifted its stake in shares of DENTSPLY SIRONA by 11.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 67,988 shares of the medical instruments supplier's stock valued at $2,420,000 after purchasing an additional 6,729 shares during the period. Finally, Wahed Invest LLC lifted its stake in shares of DENTSPLY SIRONA by 9.3% in the 4th quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier's stock valued at $128,000 after purchasing an additional 306 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.
About DENTSPLY SIRONA
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
